| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PNT | POINT Biopharma Global Inc. | Lubner David Charles | Director | Nov 23, 2022 | Buy | $6.85 | 3,600 | 24,660 | 3,600 | Nov 28, 2022, 04:03 PM | |
| RARX | Ra Pharmaceuticals, Inc. | Lubner David Charles | Executive VP and CFO | Apr 02, 2020 | Option Exercise | $48.00 | 15,622 | 749,856 | 0 | Apr 03, 2020, 09:02 AM | |
| NITE | Nightstar Therapeutics plc | Lubner David Charles | Director | Jun 07, 2019 | Option Exercise | $25.50 | 29,124 | 742,662 | 0 | Jun 07, 2019, 04:36 PM | |
| RARX | Ra Pharmaceuticals, Inc. | Lubner David Charles | Executive V.P. & CFO | Feb 01, 2019 | Option Exercise | $21.00 | 3,291 | 69,111 | 7,126 | Feb 05, 2019, 07:39 PM | |
| TTPH | TETRAPHASE PHARMACEUTICALS INC | Lubner David Charles | SVP and CFO | Aug 14, 2015 | Option Exercise | $7.94 | 9,500 | 75,430 | 78,770 | Aug 17, 2015, 05:03 PM | |
| TTPH | TETRAPHASE PHARMACEUTICALS INC | Lubner David Charles | SVP and CFO | Aug 14, 2015 | Sale | $42.92 | 9,500 | 407,740 | 69,270 | Aug 17, 2015, 05:03 PM | |
| TTPH | TETRAPHASE PHARMACEUTICALS INC | Lubner David Charles | SVP and CFO | Jul 14, 2015 | Option Exercise | $3.37 | 7,500 | 25,278 | 76,770 | Jul 15, 2015, 06:30 PM | |
| TTPH | TETRAPHASE PHARMACEUTICALS INC | Lubner David Charles | SVP and CFO | Jul 14, 2015 | Sale | $48.92 | 7,500 | 366,900 | 69,270 | Jul 15, 2015, 06:30 PM | |
| TTPH | TETRAPHASE PHARMACEUTICALS INC | Lubner David Charles | SVP and CFO | Jun 15, 2015 | Option Exercise | $2.03 | 7,500 | 15,225 | 76,770 | Jun 16, 2015, 05:11 PM | |
| TTPH | TETRAPHASE PHARMACEUTICALS INC | Lubner David Charles | SVP and CFO | Jun 15, 2015 | Sale | $41.67 | 7,500 | 312,525 | 69,270 | Jun 16, 2015, 05:11 PM | |
| TTPH | TETRAPHASE PHARMACEUTICALS INC | Lubner David Charles | SVP and CFO | Jun 12, 2015 | Sale | $41.29 | 10,000 | 412,900 | 69,270 | Jun 16, 2015, 05:11 PM | |
| TTPH | TETRAPHASE PHARMACEUTICALS INC | Lubner David Charles | SVP and CFO | May 14, 2015 | Option Exercise | $2.03 | 15,000 | 30,450 | 86,954 | May 18, 2015, 05:00 PM | |
| TTPH | TETRAPHASE PHARMACEUTICALS INC | Lubner David Charles | SVP and CFO | May 14, 2015 | Sale | $39.28 | 15,000 | 589,200 | 79,270 | May 18, 2015, 05:00 PM | |
| TTPH | TETRAPHASE PHARMACEUTICALS INC | Lubner David Charles | SVP and CFO | Jun 17, 2014 | Sale | $12.51 | 13,530 | 169,260 | 78,463 | Jun 18, 2014, 04:39 PM | |
| TTPH | TETRAPHASE PHARMACEUTICALS INC | Lubner David Charles | SVP and CFO | Mar 06, 2014 | Sale | $13.65 | 4,510 | 61,561 | 91,993 | Mar 10, 2014, 04:08 PM | |
| TTPH | TETRAPHASE PHARMACEUTICALS INC | Lubner David Charles | SVP and CFO | Feb 12, 2014 | Sale | $13.92 | 4,506 | 62,724 | 96,503 | Feb 13, 2014, 05:20 PM | |
| TTPH | TETRAPHASE PHARMACEUTICALS INC | Lubner David Charles | SVP and CFO | Feb 07, 2014 | Option Exercise | $1.58 | 88,391 | 139,435 | 110,937 | Feb 11, 2014, 04:12 PM | |
| TTPH | TETRAPHASE PHARMACEUTICALS INC | Lubner David Charles | SVP and CFO | Feb 07, 2014 | Sale | $14.22 | 9,928 | 141,176 | 101,009 | Feb 11, 2014, 04:12 PM |
Menu